Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases.
Identifieur interne : 000365 ( PubMed/Checkpoint ); précédent : 000364; suivant : 000366Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases.
Auteurs : Marcia A. Blackman [États-Unis] ; Mark A. Marchionni [États-Unis] ; John Gilly [États-Unis] ; Matthew Hepburn [États-Unis] ; Bruce L. Innis [États-Unis] ; Alan D T. Barrett [États-Unis] ; Kent E. Kester [États-Unis] ; John R. Mascola [États-Unis] ; James F. Cummings [États-Unis] ; Thomas P. Monath [États-Unis] ; M Cristina Cassetti [États-Unis] ; Jerome H. Kim [Corée du Sud] ; Melanie Saville [Royaume-Uni] ; Stephen J. Thomas [États-Unis]Source :
- Vaccine [ 1873-2518 ] ; 2019.
Abstract
Emerging and re-emerging infectious diseases are an expanding global threat to public health, security, and economies. Increasing populations, urbanization, deforestation, climate change, anti-vaccination movements, war, and international travel are some of the contributing factors to this trend. The recent Ebola, MERS-CoV, and Zika outbreaks demonstrated we are insufficiently prepared to respond with proven safe and effective countermeasures (i.e., vaccines and therapeutics). The State University of New York Upstate Medical University and the Trudeau Institute convened a summit of key opinion and thought leaders in the life sciences and biomedical research and development enterprises to explore global biopreparedness challenges, take an inventory of existing capabilities and capacities related to preparation and response, assess current "gaps," and prospect what could be done to improve our position. Herein we describe the summit proceedings, "Translational Immunology Supporting Biomedical Countermeasure Development for Emerging Vector-borne Viral Diseases," held October 2-3, 2018, at the Trudeau Institute in Saranac Lake, NY.
DOI: 10.1016/j.vaccine.2019.08.061
PubMed: 31500964
Affiliations:
- Corée du Sud, Royaume-Uni, États-Unis
- Angleterre, District de Columbia, Grand Londres, Maryland, Massachusetts, Pennsylvanie, Région capitale de Séoul, Texas, Virginie, État de New York
- Londres, Séoul
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:31500964Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases.</title><author><name sortKey="Blackman, Marcia A" sort="Blackman, Marcia A" uniqKey="Blackman M" first="Marcia A" last="Blackman">Marcia A. Blackman</name><affiliation wicri:level="2"><nlm:affiliation>Trudeau Institute, Saranac Lake, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Trudeau Institute, Saranac Lake, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Marchionni, Mark A" sort="Marchionni, Mark A" uniqKey="Marchionni M" first="Mark A" last="Marchionni">Mark A. Marchionni</name><affiliation wicri:level="2"><nlm:affiliation>Trudeau Institute, Saranac Lake, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Trudeau Institute, Saranac Lake, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Gilly, John" sort="Gilly, John" uniqKey="Gilly J" first="John" last="Gilly">John Gilly</name><affiliation wicri:level="2"><nlm:affiliation>Trudeau Institute, Saranac Lake, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Trudeau Institute, Saranac Lake, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Hepburn, Matthew" sort="Hepburn, Matthew" uniqKey="Hepburn M" first="Matthew" last="Hepburn">Matthew Hepburn</name><affiliation wicri:level="2"><nlm:affiliation>Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), Arlington, VA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), Arlington, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Innis, Bruce L" sort="Innis, Bruce L" uniqKey="Innis B" first="Bruce L" last="Innis">Bruce L. Innis</name><affiliation wicri:level="2"><nlm:affiliation>PATH, Washington, DC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>PATH, Washington, DC</wicri:regionArea><placeName><region type="state">District de Columbia</region></placeName></affiliation></author><author><name sortKey="Barrett, Alan D T" sort="Barrett, Alan D T" uniqKey="Barrett A" first="Alan D T" last="Barrett">Alan D T. Barrett</name><affiliation wicri:level="2"><nlm:affiliation>Sealy Institute for Vaccine Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Sealy Institute for Vaccine Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Kester, Kent E" sort="Kester, Kent E" uniqKey="Kester K" first="Kent E" last="Kester">Kent E. Kester</name><affiliation wicri:level="2"><nlm:affiliation>Sanofi Pasteur, Swiftwater, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Sanofi Pasteur, Swiftwater, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Mascola, John R" sort="Mascola, John R" uniqKey="Mascola J" first="John R" last="Mascola">John R. Mascola</name><affiliation wicri:level="2"><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Cummings, James F" sort="Cummings, James F" uniqKey="Cummings J" first="James F" last="Cummings">James F. Cummings</name><affiliation wicri:level="1"><nlm:affiliation>ICON Government and Public Health Solutions, Washington, D.C., USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>ICON Government and Public Health Solutions, Washington, D.C.</wicri:regionArea><wicri:noRegion>D.C.</wicri:noRegion></affiliation></author><author><name sortKey="Monath, Thomas P" sort="Monath, Thomas P" uniqKey="Monath T" first="Thomas P" last="Monath">Thomas P. Monath</name><affiliation wicri:level="2"><nlm:affiliation>Crozet BioPharma LLC, Devens, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Crozet BioPharma LLC, Devens, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Cassetti, M Cristina" sort="Cassetti, M Cristina" uniqKey="Cassetti M" first="M Cristina" last="Cassetti">M Cristina Cassetti</name><affiliation wicri:level="2"><nlm:affiliation>Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH, Rockville, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH, Rockville, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Kim, Jerome H" sort="Kim, Jerome H" uniqKey="Kim J" first="Jerome H" last="Kim">Jerome H. Kim</name><affiliation wicri:level="3"><nlm:affiliation>International Vaccine Institute, Seoul, South Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>International Vaccine Institute, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Saville, Melanie" sort="Saville, Melanie" uniqKey="Saville M" first="Melanie" last="Saville">Melanie Saville</name><affiliation wicri:level="3"><nlm:affiliation>Coalition for Epidemic Preparedness Innovations (CEPI), London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Coalition for Epidemic Preparedness Innovations (CEPI), London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Thomas, Stephen J" sort="Thomas, Stephen J" uniqKey="Thomas S" first="Stephen J" last="Thomas">Stephen J. Thomas</name><affiliation wicri:level="2"><nlm:affiliation>Division of Infectious Diseases, State University of New York, Upstate Medical University, Syracuse, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Infectious Diseases, State University of New York, Upstate Medical University, Syracuse, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:31500964</idno><idno type="pmid">31500964</idno><idno type="doi">10.1016/j.vaccine.2019.08.061</idno><idno type="wicri:Area/PubMed/Corpus">000425</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000425</idno><idno type="wicri:Area/PubMed/Curation">000425</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000425</idno><idno type="wicri:Area/PubMed/Checkpoint">000365</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000365</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases.</title><author><name sortKey="Blackman, Marcia A" sort="Blackman, Marcia A" uniqKey="Blackman M" first="Marcia A" last="Blackman">Marcia A. Blackman</name><affiliation wicri:level="2"><nlm:affiliation>Trudeau Institute, Saranac Lake, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Trudeau Institute, Saranac Lake, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Marchionni, Mark A" sort="Marchionni, Mark A" uniqKey="Marchionni M" first="Mark A" last="Marchionni">Mark A. Marchionni</name><affiliation wicri:level="2"><nlm:affiliation>Trudeau Institute, Saranac Lake, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Trudeau Institute, Saranac Lake, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Gilly, John" sort="Gilly, John" uniqKey="Gilly J" first="John" last="Gilly">John Gilly</name><affiliation wicri:level="2"><nlm:affiliation>Trudeau Institute, Saranac Lake, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Trudeau Institute, Saranac Lake, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Hepburn, Matthew" sort="Hepburn, Matthew" uniqKey="Hepburn M" first="Matthew" last="Hepburn">Matthew Hepburn</name><affiliation wicri:level="2"><nlm:affiliation>Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), Arlington, VA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), Arlington, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Innis, Bruce L" sort="Innis, Bruce L" uniqKey="Innis B" first="Bruce L" last="Innis">Bruce L. Innis</name><affiliation wicri:level="2"><nlm:affiliation>PATH, Washington, DC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>PATH, Washington, DC</wicri:regionArea><placeName><region type="state">District de Columbia</region></placeName></affiliation></author><author><name sortKey="Barrett, Alan D T" sort="Barrett, Alan D T" uniqKey="Barrett A" first="Alan D T" last="Barrett">Alan D T. Barrett</name><affiliation wicri:level="2"><nlm:affiliation>Sealy Institute for Vaccine Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Sealy Institute for Vaccine Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Kester, Kent E" sort="Kester, Kent E" uniqKey="Kester K" first="Kent E" last="Kester">Kent E. Kester</name><affiliation wicri:level="2"><nlm:affiliation>Sanofi Pasteur, Swiftwater, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Sanofi Pasteur, Swiftwater, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Mascola, John R" sort="Mascola, John R" uniqKey="Mascola J" first="John R" last="Mascola">John R. Mascola</name><affiliation wicri:level="2"><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Cummings, James F" sort="Cummings, James F" uniqKey="Cummings J" first="James F" last="Cummings">James F. Cummings</name><affiliation wicri:level="1"><nlm:affiliation>ICON Government and Public Health Solutions, Washington, D.C., USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>ICON Government and Public Health Solutions, Washington, D.C.</wicri:regionArea><wicri:noRegion>D.C.</wicri:noRegion></affiliation></author><author><name sortKey="Monath, Thomas P" sort="Monath, Thomas P" uniqKey="Monath T" first="Thomas P" last="Monath">Thomas P. Monath</name><affiliation wicri:level="2"><nlm:affiliation>Crozet BioPharma LLC, Devens, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Crozet BioPharma LLC, Devens, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Cassetti, M Cristina" sort="Cassetti, M Cristina" uniqKey="Cassetti M" first="M Cristina" last="Cassetti">M Cristina Cassetti</name><affiliation wicri:level="2"><nlm:affiliation>Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH, Rockville, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH, Rockville, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Kim, Jerome H" sort="Kim, Jerome H" uniqKey="Kim J" first="Jerome H" last="Kim">Jerome H. Kim</name><affiliation wicri:level="3"><nlm:affiliation>International Vaccine Institute, Seoul, South Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>International Vaccine Institute, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Saville, Melanie" sort="Saville, Melanie" uniqKey="Saville M" first="Melanie" last="Saville">Melanie Saville</name><affiliation wicri:level="3"><nlm:affiliation>Coalition for Epidemic Preparedness Innovations (CEPI), London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Coalition for Epidemic Preparedness Innovations (CEPI), London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Thomas, Stephen J" sort="Thomas, Stephen J" uniqKey="Thomas S" first="Stephen J" last="Thomas">Stephen J. Thomas</name><affiliation wicri:level="2"><nlm:affiliation>Division of Infectious Diseases, State University of New York, Upstate Medical University, Syracuse, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Infectious Diseases, State University of New York, Upstate Medical University, Syracuse, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Emerging and re-emerging infectious diseases are an expanding global threat to public health, security, and economies. Increasing populations, urbanization, deforestation, climate change, anti-vaccination movements, war, and international travel are some of the contributing factors to this trend. The recent Ebola, MERS-CoV, and Zika outbreaks demonstrated we are insufficiently prepared to respond with proven safe and effective countermeasures (i.e., vaccines and therapeutics). The State University of New York Upstate Medical University and the Trudeau Institute convened a summit of key opinion and thought leaders in the life sciences and biomedical research and development enterprises to explore global biopreparedness challenges, take an inventory of existing capabilities and capacities related to preparation and response, assess current "gaps," and prospect what could be done to improve our position. Herein we describe the summit proceedings, "Translational Immunology Supporting Biomedical Countermeasure Development for Emerging Vector-borne Viral Diseases," held October 2-3, 2018, at the Trudeau Institute in Saranac Lake, NY.</div></front></TEI><pubmed><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">31500964</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>43</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases.</ArticleTitle><Pagination><MedlinePgn>6248-6254</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(19)31137-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2019.08.061</ELocationID><Abstract><AbstractText>Emerging and re-emerging infectious diseases are an expanding global threat to public health, security, and economies. Increasing populations, urbanization, deforestation, climate change, anti-vaccination movements, war, and international travel are some of the contributing factors to this trend. The recent Ebola, MERS-CoV, and Zika outbreaks demonstrated we are insufficiently prepared to respond with proven safe and effective countermeasures (i.e., vaccines and therapeutics). The State University of New York Upstate Medical University and the Trudeau Institute convened a summit of key opinion and thought leaders in the life sciences and biomedical research and development enterprises to explore global biopreparedness challenges, take an inventory of existing capabilities and capacities related to preparation and response, assess current "gaps," and prospect what could be done to improve our position. Herein we describe the summit proceedings, "Translational Immunology Supporting Biomedical Countermeasure Development for Emerging Vector-borne Viral Diseases," held October 2-3, 2018, at the Trudeau Institute in Saranac Lake, NY.</AbstractText><CopyrightInformation>Copyright © 2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blackman</LastName><ForeName>Marcia A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Trudeau Institute, Saranac Lake, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchionni</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Trudeau Institute, Saranac Lake, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilly</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Trudeau Institute, Saranac Lake, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hepburn</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), Arlington, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Innis</LastName><ForeName>Bruce L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>PATH, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrett</LastName><ForeName>Alan D T</ForeName><Initials>ADT</Initials><AffiliationInfo><Affiliation>Sealy Institute for Vaccine Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kester</LastName><ForeName>Kent E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Sanofi Pasteur, Swiftwater, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mascola</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cummings</LastName><ForeName>James F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>ICON Government and Public Health Solutions, Washington, D.C., USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monath</LastName><ForeName>Thomas P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Crozet BioPharma LLC, Devens, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassetti</LastName><ForeName>M Cristina</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH, Rockville, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jerome H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>International Vaccine Institute, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saville</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Coalition for Epidemic Preparedness Innovations (CEPI), London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, State University of New York, Upstate Medical University, Syracuse, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>05</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>08</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>08</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31500964</ArticleId><ArticleId IdType="pii">S0264-410X(19)31137-5</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2019.08.061</ArticleId><ArticleId IdType="pmc">PMC7131820</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cell Stem Cell. 2017 Mar 2;20(3):385-396.e3</Citation><ArticleIdList><ArticleId IdType="pubmed">28041895</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4458-63</Citation><ArticleIdList><ArticleId IdType="pubmed">27044104</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS Negl Trop Dis. 2016 Aug 10;10(8):e0004866</Citation><ArticleIdList><ArticleId IdType="pubmed">27509037</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2012 Jun 29;30(31):4638-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22583812</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2013 Sep;87(18):10324-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23864620</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Gen Virol. 2013 Dec;94(Pt 12):2700-2709</Citation><ArticleIdList><ArticleId IdType="pubmed">24092759</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS Pathog. 2018 Apr 10;14(4):e1006994</Citation><ArticleIdList><ArticleId IdType="pubmed">29634758</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Protein Cell. 2017 Nov;8(11):823-833</Citation><ArticleIdList><ArticleId IdType="pubmed">29058117</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Organogenesis. 2014 Apr-Jun;10(2):159-63</Citation><ArticleIdList><ArticleId IdType="pubmed">24762764</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>BMJ. 2015 Jul 27;351:h3740</Citation><ArticleIdList><ArticleId IdType="pubmed">26215666</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Immunol. 2018 Jan;19(1):20-28</Citation><ArticleIdList><ArticleId IdType="pubmed">29199281</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vet Microbiol. 2013 Sep 27;166(1-2):145-53</Citation><ArticleIdList><ArticleId IdType="pubmed">23834965</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Corée du Sud</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>District de Columbia</li><li>Grand Londres</li><li>Maryland</li><li>Massachusetts</li><li>Pennsylvanie</li><li>Région capitale de Séoul</li><li>Texas</li><li>Virginie</li><li>État de New York</li></region><settlement><li>Londres</li><li>Séoul</li></settlement></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Blackman, Marcia A" sort="Blackman, Marcia A" uniqKey="Blackman M" first="Marcia A" last="Blackman">Marcia A. Blackman</name></region><name sortKey="Barrett, Alan D T" sort="Barrett, Alan D T" uniqKey="Barrett A" first="Alan D T" last="Barrett">Alan D T. Barrett</name><name sortKey="Cassetti, M Cristina" sort="Cassetti, M Cristina" uniqKey="Cassetti M" first="M Cristina" last="Cassetti">M Cristina Cassetti</name><name sortKey="Cummings, James F" sort="Cummings, James F" uniqKey="Cummings J" first="James F" last="Cummings">James F. Cummings</name><name sortKey="Gilly, John" sort="Gilly, John" uniqKey="Gilly J" first="John" last="Gilly">John Gilly</name><name sortKey="Hepburn, Matthew" sort="Hepburn, Matthew" uniqKey="Hepburn M" first="Matthew" last="Hepburn">Matthew Hepburn</name><name sortKey="Innis, Bruce L" sort="Innis, Bruce L" uniqKey="Innis B" first="Bruce L" last="Innis">Bruce L. Innis</name><name sortKey="Kester, Kent E" sort="Kester, Kent E" uniqKey="Kester K" first="Kent E" last="Kester">Kent E. Kester</name><name sortKey="Marchionni, Mark A" sort="Marchionni, Mark A" uniqKey="Marchionni M" first="Mark A" last="Marchionni">Mark A. Marchionni</name><name sortKey="Mascola, John R" sort="Mascola, John R" uniqKey="Mascola J" first="John R" last="Mascola">John R. Mascola</name><name sortKey="Monath, Thomas P" sort="Monath, Thomas P" uniqKey="Monath T" first="Thomas P" last="Monath">Thomas P. Monath</name><name sortKey="Thomas, Stephen J" sort="Thomas, Stephen J" uniqKey="Thomas S" first="Stephen J" last="Thomas">Stephen J. Thomas</name></country><country name="Corée du Sud"><region name="Région capitale de Séoul"><name sortKey="Kim, Jerome H" sort="Kim, Jerome H" uniqKey="Kim J" first="Jerome H" last="Kim">Jerome H. Kim</name></region></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Saville, Melanie" sort="Saville, Melanie" uniqKey="Saville M" first="Melanie" last="Saville">Melanie Saville</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000365 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000365 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:31500964
|texte= Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:31500964" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |